This is just a wonderful, enthusiastic new @yMICUK_yESMI leadership team - welcome to the youngESMI family! And they are taking off 🚀: pre-British #EMIM2022 day on 4 March in London to practice your presentation for Thessaloniki... more to come!
It's not every day that you get an invite to review your own grant application. Via my Oxford email I got a request to review a grant submitted by me in Groningen. Although I feel I'm an expert in my field 😇, somehow it doesn't seem right ... 😆
Meet Claudia Fraser, our scientist of the week! @ClaudiaFraser9 is a DPhil student in the @Cornelissen_Lab.
Thank you @DoreenLau4 for your nomination!
Nominate your friends and colleagues!
https://t.co/qPT4tnUqJ5
Using our copper-mediated radiofluorination technology, we have developed a radiosynthesis to access [18F]Rucaparib. Out now in @JOC_OL in collaboration with @Cornelissen_Lab!
Congratulations to Zijun, @DestroGianluca, Florian and Chung Ying!
https://t.co/dsb0GWzIRu
We've got a fully funded place for an enthusiastic PhD student to work on radiopharmaceuticals for imaging and therapy of cancer, at the department of nuclear medicine at the University Medical Center in Groningen, the Netherlands. Get in touch!
We've been enjoying the #SNMMI21 meeting so far! Check out our work on:
➡️Imaging PARP with 18F-rucaparib (1516; Kathy, @DestroGianluca)
➡️ 18F-labelled ATM inhibitors (1457; Javier, @ClaudiaFraser9)
➡️ 177Lu-PSMA combination therapies (94; @TiffanyGKChan, @NuclearMedEd)
Our summer newsletter is filled with all the latest research and PCR news. From radiotherapy to hunt out prostate cancer to exploring the genetics behind the disease. Order your copy from our website https://t.co/lGebqOrOdc
Last week, I started my new post at UMCG in the Netherlands. Looking forward to getting stuck in and developing creative new radiochemistry, imaging and theragnostics projects with my new colleagues. The group at Oxford carries on, under my direction. Exciting times!
We have two new fantastic Post Doc opportunities in Immuno-oncology and pancreatic cancer. We are taking our established cell and molecular work into immune cells in collaboration with immunologists at Oxford.
https://t.co/z6ExEc4NN4
https://t.co/k3zOc3TRbI
We’d like to thank @HSFCharity for their generous donation in support of our ‘Improving Radiotherapy’ project led by Professor Cornelissen at the University of Oxford. Their donation will support research into new treatments which could drastically improve the lives of patients.
PCR scientists, Professor Bart Cornelissen and Dr @TiffanyGKChan appeared on BBC South Today @BBCSouthNews to talk about their new award for research into improving Lu-PSMA radiotherapy. Watch from 6:40 to find out more https://t.co/0ZfqfjCP44
@Cornelissen_Lab@OxfordOncology
Proof-of-concept study: A model system can be used to evaluate and improve intranuclear PET/SPECT imaging, with great potential for the development of a range of clinical applications not currently possible. #MedicalResearch#NucMed#PETimaging https://t.co/KmHrREbiLG
Congratulations to the Department's Bart Cornelissen and @TiffanyGKChan on their success in obtaining further funding from @PCR_News to hunt out cancer cells using innovative radiotherapy techniques.
https://t.co/vqvbpVVJWq
What's the lowest detection threshold for successful imaging of intranuclear epitopes using IgG-TAT-based radioimmunoconjugates? Have a read of @MathewVeal's work, out now in @JournalofNucMed!
https://t.co/O5a60uvXeB